http://www.fpnotebook.com/
Thyroid Hormone Replacement
Aka: Thyroid Hormone Replacement, Thyroid Replacement, Levothyroxine, Synthroid, Thyroxine Replacement, T4 Replacement- Indications
- Preparations
- Generic Levothyroxine are of similar quality to brand drugs
- However agents from different manufacturers are not bioequivalent
- When manufacturer changes, recheck TSH level in 6 weeks after change
- See oral and intravenous dosing below
- Generic Levothyroxine are of similar quality to brand drugs
- Drug Interactions (Take 4 hours apart)
- Grapefruit should be avoided regardless of time taken
- Interfere with GI absorption (lower levels)
- Cholestyramine
- Colestipol
- Ferrous Sulfate
- Orlistat
- Sucralfate
- Aluminum hydroxide antacids
- Calcium Supplementation
- Soy products
- Increase metabolism of Thyroxine (lowers levels)
- Phenytoin (Dilantin)
- Carbamazepine (Tegretol)
- Rifampin
- Phenobarbital
- Warfarin (Coumadin)
- Oral Hypoglycemic agents
- Selective Serotonin Reuptake Inhibitors or Tricyclic Antidepressants
- Most common with Sertraline (Zoloft)
- Medications interfere with T4 production (lower levels)
- Lithium
- Amiodarone
- Medications containing iodine
- Medications increasing protein binding (lowers levels)
- Pregnancy (high Estrogenic state)
- Oral Contraceptive
- Estrogen Replacement
- Medications decreasing protein binding (raises levels)
- Furosemide (Lasix)
- Mefenamic acid (Ponstel)
- Salicylates
- Androgens
- Decreased Serum Proteins with aging
- Nephrotic Syndrome
- Cirrhosis
- Protein-losing Enteropathy
- Dosing (lower dosing in Subclinical Hypothyroidism)
- See Subclinical Hypothyroidism
- Dosing precautions
- Take Levothyroxine at a consistent time each day
- Doses should be taken 60 minutes before meals
- Commonly taken before breakfast or at bedtime
- Avoid within 4 hours of products that decrease Levothyroxine absorption
- See drug interactions above
- Anticipated total dose (50 to 200 mcg/day)
- Children: up to 4 mcg/kg/day (full replacement)
- Adults: 1.6 mcg/kg/day
- Elderly: 1 mcg/kg/day
- Younger persons (no comorbid conditions)
- Usual starting dose: 75 to 100 mcg daily
- Options for initiating dosing
- Option 1
- Start at 75 to 100 mcg qd
- Option 2
- Start at 0.8 mcg/kg/day (50% of anticipated dose)
- Increase to 1.6 mcg/kg/day at 2 weeks
- Option 1
- Age over 50 years or history of heart disease
- Start at 25-50 mcg daily
- Increase by 25 mcg increments every 4 weeks until full replacement dose reached
- Follow Thyroid Stimulating Hormone (TSH) closely
- Dosing: Pregnancy
- Endocrinology consult
- Increase Levothyroxine dose at earliest knowledge of pregnancy
- Pregnancy requires an increased Levothyroxine dose
- Increased dose by 30-47% over baseline required in most pregnant patients
- Increased dose required for remainder of pregnancy (with frequent monitoring of TSH)
- Add 2 additional doses per week (9 total doses)
- Example
- Patient on 100 mcg daily before pregnancy
- When pregnancy diagnosed, start taking an extra dose (total 200 mcg) on Tuesday and Saturday
- Recheck Thyroid Stimulating Hormone (TSH) at 5 weeks after dose change
- Decrease dose to baseline immediately after delivery, and recheck TSH in 6-8 weeks
- Pregnancy requires an increased Levothyroxine dose
- TSH Monitoring
- TSH at earliest pregnancy diagnosis (Levothyroxine increased at this time)
- TSH 5 weeks after initial Levothyroxine increase and every 4-5 weeks after dose change
- TSH a minimum of every trimester
- TSH at 6-8 weeks after delivery (levoothyroxine dose decreased to baseline at delivery)
- Management: Intravenous dosing
- Indicated if unable to take oral dose for >7 days
- Parenteral dose is 70-80% of usual oral dose
- Adverse Effects: Excessive Thyroid Replacement
- Osteoporosis
- Atrial Fibrillation
- Cardiac hypertrophy
- Increased Intraventricular septum thickness
- Increased Left Ventricular posterior wall thickness
- Increased End Diastolic Dimension
- Increased Left Ventricular Mass Index
- Decreased Exercise Tolerance
- Decreased VO2 Max
- Decreased Anaerobic threshold
- Monitoring
- Protocols for monitoring
- Monitoring every 6 to 8 weeks
- TSH not yet stabilized after initiation
- Recent change in Thyroid Replacement dosing
- Recent change in manufacturer
- Consider monitoring less frequently than annually (usually done annually in this group)
- Requires dose stable
- Age under 50 years with weight stable
- No comorbid condition
- Monitoring at least annually (when on stable dose)
- Age over 50 years
- Weight change
- Monitoring every 6 to 8 weeks
- Specific Testing
- Thyroid Stimulating Hormone
- Lags Levothyroxine dose change by 6 weeks
- Target adjusting TSH to the normal mid-range (<3 mg/dl)
- Thyroxine (T4)
- Lags Levothyroxine dose change by 1-2 weeks
- Thyroid Stimulating Hormone
- Protocols for monitoring
- References